Psychometric properties of the Spanish version of the screening scale for DSM-IV generalized anxiety disorder of Carroll and Davidson

Actas Espanolas de Psiquiatria

Volumn 34, Issue 2, 2006, Pages 83-93

  Bobes, Julio ^a   Garcia Calvo C ^b   Prieto, R ^b   Garcia Garcia M ^c   Rico Villademoros, F ^c   Antón, Pedro ^d   Bascarán, M Teresa ^a   Chamorro, Lorenzo ^e   Chinchilla, Alfonso ^f   De Dios, Consuelo ^g   García, Olga ^h   García Campayo, Javier ⁱ   Gil, Patxi ^j   González, Antonio ^k   García Portilla, M Paz ^a   Herrán, Andrés ^l   Jiménez, Miguel Ángel ^m   Macías, José Ángel ⁿ   Massana, Guillem ^o   Pérez, Antonio ^p   Pigem, José Ramón ^q   Pujol, Jordi ^r   Rodriguez, José Juan ^s   Sala, José M ^t   Sanchez, Ángel ^u   Serrano, Manuel ^v   Sopelana, Pedro ^w   Zapico, Yolanda ^x   more..

^a UNIVERSITY OF OVIEDO   (Spain)

^b Laboratories Wyeth Farma SA   (Spain)

^c Biometrica   (Spain)

^d Clinica Mediterranea de Neurociencias   (Spain)

^e Regional General Hospital   (Mexico)

^f HOSPITAL RAMÓN Y CAJAL   (Spain)

^g C S M Castroviejo   (Spain)

^h C S M Sur   (Spain)

ⁱ C S Torrero   (Spain)

^j C S M Sestao   (Spain)

^k Equipo de Salud Mental   (Spain)

^l HOSPITAL UNIVERSITARIO MARQUÉS DE VALDECILLA   (Spain)

^m C S M Arganzuela   (Spain)

ⁿ HOSPITAL CLÍNICO UNIVERSITARIO DE VALLADOLID   (Spain)

^o HOSPITAL CLÍNIC   (Spain)

^p Centro de Salud San Juan   (Spain)

^q Clinica Bellavista   (Spain)

^r Hospital Comarcal de Mora   (Spain)

^s C S M Colmenar   (Spain)

^t HOSPITAL CLÍNICO UNIVERSITARIO LOZANO BLESA   (Spain)

^u HOSPITAL UNIVERSITARIO VIRGEN DE LA ARRIXACA   (Spain)

^v HOSPITAL JUAN CANALEJO   (Spain)

^w C S M Reyes Magos   (Spain)

^x HOSPITAL EL BIERZO   (Spain)

more..

Author keywords

Anxiety; Disorders depression; Validation; Venlafaxine

Indexed keywords

ADULT; ANXIETY DISORDER; ARTICLE; DIAGNOSTIC AND STATISTICAL MANUAL OF MENTAL DISORDERS; FEMALE; HUMAN; LANGUAGE; MALE; MASS SCREENING; METHODOLOGY; PSYCHOMETRY; QUESTIONNAIRE; REPRODUCIBILITY; SPAIN; STATISTICS; TIME; VALIDATION STUDY;

ADULT; ANXIETY DISORDERS; DIAGNOSTIC AND STATISTICAL MANUAL OF MENTAL DISORDERS; FEMALE; HUMANS; LANGUAGE; MALE; MASS SCREENING; PSYCHOMETRICS; QUESTIONNAIRES; REPRODUCIBILITY OF RESULTS; SPAIN; TIME FACTORS;

EID: 33646355974     PISSN: 11399287     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (31)

1. rd ed. Washington: American Psychiatric Association, 1980.
2. th ed. rev. Washington: American Psychiatric Association, 2000.
3. rd ed. rev. Washington: American Psychiatric Association, 1987.
4. th ed. Washington: American Psychiatric Association, 1994.
5. Kessler RC, Wittchen HU. Patterns and correlates of generalized anxiety disorder in community samples. J Clin Psychiatry 2002; 63(Suppl. 8):4-10.
6. Maier W, Gansicke M, Freyberger HJ, Linz M, Heun R, Lecrubier Y. Generalized anxiety disorder (ICD-10) in primary care from a cross-cultural perspective: a valid diagnostic entity? Acta Psychiatr Scand 2000;101:29-36.
7. Kupfer DJ, First MB, Regier DA. A research agenda for DSM-V. Washington: American Psychiatric Association, 2002.
8. Allgulander C. Generalized anxiety disorder: current challenges and future options. Estocolmo: comunicación presentada en el 14 Congreso ECNP, 2004.
9. Hamilton M. The assessment of anxiety states by rating. Br J Med Psychol 1959;32:50-5.
10. Echeburúa Odriozola E. Medición clínica en trastornos fóbicos y de ansiedad. En: Bulbena A, Berrios GE, Fernández de Larrinoa P, editores. Medición clinica en psiquiatría y psicología. Barcelona: Masson, 2002.
11. Rocca P, Fonza V, Scotta M, Sanadla E, Ravizza L. Paroxetine efficacy in the treatment of generalized anxiety disorder. Acta Psychiatr Scand 1997;95:444-50.
12. Davidson JRT, DuPont RL, Hedges D, Haskins JT. Efficacy, safety and tolerability of venlafaxine extended release and buspirone in outpatients with generalized anxiety disorder. J Clin Psychiatry 1999;60:528-35.
13. Rickels K, Pollack MH, Sheehan DV, Haskins JT. Efficacy of extended-release venlafaxine in nondepressed outpatients with generalized anxiety disorder. Am J Psychiatry 2000;157:969-74.
14. Gelenberg AJ, Lydiard RB, Rudolph RL, Aguiar L, Haskins JT, Salinas E. Efficacy of venlafaxine extended-release capsules in nondepressed outpatients with generalized anxiety disorder: a 6-month randomized controlled trial. JAMA 2000;283:3082-8.
15. Allgulander C, Hackett D, Salinas E. Venlafaxine extended release (ER) in the treatment of generalised anxiety disorder. Br J Psychiatr 2001;179:15-22.
16. Meyer TJ, Miller ML, Metzger RL, Borkovec TD. Development and validation of the Penn State Worry Questionnaire. Behav Res Ther 1990;28:487-95.
17. Allgulander C, Nilsson B. A nationwide study in primary health care: one out of four patients suffers from anxiety and depression. Lakartidningen 2003;100:832-8.
18. th Annual Meeting (NR193). New York, 2004.
19. Wan GJ, Geissler EC, Zhang HF, Hackett D. Assessment of Symptom-Free Days in GAD. Communication presented in the American Psychiatric Association 156th Annual Meeting (NR623). San Francisco, 2003.
20. Wittchen HU, Boyer P. Screening for anxiety disorders. Sensitivity and specifity of the Anxiety Screening Questionnaire (ASQ-15). Br J Psychiatry 1998;173(Suppl. 34):10-7.
21. Carroll BJ, Davidson JRT. Screening Scale for DSM-IV GAD. Copyright, 2000.
22. Guy W. Early Clinical Drug Evaluation Unit (ECDEU) assessment manual for psychopharmacology. Revised. NIMH publication DHEW publ NO (Adm) 76-338. Bethesda: National Institute of mental Health, 1976; p. 217-22.
23. Hamilton M. The assessment of anxiety by rating. Br J Med Psychol 1959;32:50-5.
24. Kazis LE, Anderson JJ, Meenan RF. Effect sizes for interpreting changes in health status. Med Care 1989;27:S178-89.
25. Nunnally JC. Psychometric theory. New York: McGraw-Hill, 1978.
26. Stein DJ. Comorbidity in generalized anxiety disorder: impact and implications. J Clin Psychiatry 2001;62(Suppl. 11):29-34.
27. Wittchen HU, Hoyer J. Generalized anxiety disorder: nature and course. J Clin Psychiatry 2001;62(Suppl. 11):15-21.
28. Wittchen HU, Zhao S, Kessler RC, Eaton WW. DSM-III-R generalized anxiety disorder in the National Comorbidity Survey. Arch Gen Psychiatry 1994;51:355-64.
29. American Psychiatric Association. Manual diagnóstico y estadistico de los trastornos mentales. Versión española de la cuarta edición de la obra original en lengua inglesa. Barcelona: Masson, 1995.
30. Guyatt GH. A taxonomy of health status instruments. J Rheumatol 1995;22:1188-90.
31. Lobo A, Chamorro L, Luque A, Dal-Re R, Badia X, Baro E. Grupo de Validación en Español de Escalas Psicométricas (GVEEP). Validation of the Spanish versions of the Montgomery-Asberg depression and Hamilton anxiety rating scales. Med Clin (Barc) 2002;118:493-9.